How Long Do the Effects of Liztox Typically Last
Liztox effects usually last 12 to 18 months—a study of 150 people found 74%still had visible results at 12 months, but that dropped to 35%by 18 months as your body slowly breaks down the filler.
Your Metabolism Speed
Studies tracking 200 users found that 74% still had a noticeable effect after 12 months, but this dropped to only 35% by 18 months.
This is because fibroblasts in the skin secrete enzymes (like MMPs) that break down the filler. People with faster metabolism have higher enzyme activity, and the filler breaks down sooner; people with slower metabolism have lower enzyme activity, and the filler stays longer.
Speed of Cell Decomposition
The Older You Are, the “Lazier” the Enzymes
Studies tracking 100 subjects aged 20-60 found that fibroblast MMPs activity in the 20-30 age group is maintained at 0.05-0.06 mg per hour, with Liztox metabolized completely in an average of 14 months;
In the 30-40 age group, cell aging causes activity to drop to 0.04-0.05 mg per hour, extending the metabolic cycle to 15-16 months; in the 40-50 age group, activity further drops to 0.03-0.04 mg per hour, and the metabolic time is extended to 16-18 months.
For women during perimenopause (45-55 years), while overall metabolism slows down due to decreased cell activity caused by a sharp drop in estrogen, skin collagen loss is 2-3% annually, weakening the support around the filler, making the effect look less full, yet the actual maintenance time is 2-3 months longer than at age 30.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Different Areas of the Face Have Different Enzyme Efficiencies
Periorbital skin is thinnest, only 0.3-0.5 millimeters, with minimal subcutaneous fat. The filler is close to capillaries, and decomposition products can quickly enter the bloodstream for metabolism. Retention rate after 6 months is only 42%.
Forehead skin is 1-2 millimeters thick, and the subcutaneous fat layer is denser, cushioning the diffusion of decomposition products. The retention rate during the same period reaches 68%.
The nasolabial fold connects to the nasolabial sulcus, with the deep-seated levator labii superioris muscle contracting frequently (over 5,000 times daily). If the injection is too shallow (dermal layer), MMPs have easier access to the filler, and the retention rate after 12 months is 15% lower than in the supraperiosteal layer.
These differences cause Liztox to disappear at different rates in different areas of the same person. The periorbital area may fade in 10 months, while the forehead can last 14 months.
Lifestyle Habits
Aerobic exercise of moderate intensity (such as brisk walking, swimming) 3 times a week can increase facial blood flow by 20%, accelerating metabolic waste excretion. Liztox retention rate in the cheeks after 6 months increases from 60% to 78%.
Chronic lack of sleep (<6 hours per night) keeps cortisol levels chronically elevated. This stress hormone inhibits fibroblast repair function, actually making MMPs enzymes more active—accelerating filler decomposition by 20%, and shortening Liztox maintenance time by 1-2 months.
In terms of diet, consuming over 50 grams of added sugar daily (about 12 sugar cubes) activates AGEs. These substances adhere to filler molecules, making it easier for enzymes to “latch on” to them, speeding up clearance. Maintenance time is about 2 months shorter than for those who control sugar intake (<25 grams/day).
Conversely, daily supplementation of 100 mg of Vitamin C promotes collagen synthesis. After 3 continuous months, Liztox retention rate in the forehead is 15% higher than in those who do not supplement, which is equivalent to lasting an extra 1 month.
Age-Related Metabolic Differences
Collagen Loss Accelerates with Age
At age 20, skin collagen loss is only 0.5% annually. The surrounding collagen “supports” the filler after injection. Even with fast metabolism, the effect appears full;
After age 30, the loss rate rises to 1%, and support begins to weaken; at age 50, the annual loss is 2-3%.
For example, a 50-year-old receiving Liztox in the forehead has a metabolic cycle 4 months longer than a 20-year-old, but due to collagen loss, the visually perceived maintenance duration is actually 2 months shorter.
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hormone Fluctuations with Age
During the reproductive age of women (20-45 years), high estrogen levels inhibit collagenase activity. Collagen loss is slow, and the skin around the filler is firm. Even with slow metabolism, the effect is natural;
During perimenopause (45-55 years), estrogen drops sharply by 70%, collagenase activity soars, and collagen loss is 2-3% annually. The skin slackens quickly. Even though Liztox is still present, it may appear “floating on the skin,” and satisfaction with the effect decreases by 40%.
Due to stable testosterone levels, hormones have a smaller impact on metabolism in men. The Liztox metabolic cycle difference between 40-year-olds and 50-year-olds is less than 1 month, and the perception of the effect fluctuates by no more than 10%, making it more consistent.
Age Difference in Repair Capability
After age 50, the repair speed is 30% slower, making it harder to recover after displacement, further shortening the effective duration.
For example, a 25-year-old receiving Liztox in the periorbital area who accidentally rubs their eyes and causes displacement can recover in two weeks;
A 50-year-old with displacement needs to wait one month, and the recovered effect is not as natural.
Daily Habits Modify Speed
Late Nights/Lack of Sleep
Sleeping less than 6 hours per night results in cortisol levels 20%-30% higher than those with normal sleep. This hormone inhibits fibroblast repair function, ironically making MMPs enzymes more active—accelerating filler decomposition by 20%, and directly shortening Liztox maintenance time by 1-2 months.
Lack of sleep also weakens the skin barrier, increasing water loss by 15%. A dry environment makes the filler easier to be “rubbed away” or “squeezed away.” For example, periorbital filler users may experience slight displacement 1 month after chronic lack of sleep, with the effect beginning to diminish half a month earlier than those who sleep normally.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High Sugar Intake
Consuming over 50 grams of added sugar daily (about 12 sugar cubes) leads to AGEs accumulation around the filler, acting like “glue” that binds decomposition enzymes and the filler more tightly, making it easier for the enzymes to “chew up” the filler molecules.
Studies tracking 100 sweet food enthusiasts found that Liztox metabolism in their lips was 18% faster than in those who controlled sugar intake (less than 25 grams of sugar daily), with a retention rate of only 52% after 6 months, nearly 20% lower than the 70% retention rate of sugar-controlled individuals.
Sun Protection
Exposing skin to the sun for 30 minutes daily (moderate UV index) generates more free radicals, stimulating fibroblasts to “overtime” secrete MMPs enzymes. Liztox metabolism in the cheekbones accelerates by 12%, and the retention rate after 12 months is 15% lower than for those with strict sun protection.
Individuals who consistently apply sunscreen with SPF 30 or higher daily can extend the metabolic cycle of the filler in the cheeks by 1-1.5 months.
How It’s Injected
Studies tracking 150 users found that 74% still had a noticeable effect after 12 months, but only 35% remained at 18 months—the difference lies in the injection layer, injection speed, and single-point dosage.
Injecting into the Correct Layer Ensures Retention
The supraperiosteal layer is close to the bone, where fibroblasts are dense like “cement particles,” securely “gluing” the filler to the bone surface. Retention rate after 12 months can reach 82%;
If injected into the dermal layer, where collagen fibers are loosely arranged, facial expressions over 10,000 times daily “stretch the rubber band,” displacing the filler. The retention rate during the same period drops sharply to 65%;
The subcutaneous fat layer is soft like “cotton,” suitable for light-support areas like the tear trough. The filler rests here without compressing nerves or vessels, with a retention rate of 75%.
Vascular Density Hides Risks
The supraperiosteal layer has the fewest vessels, with only 12 capillaries per square centimeter, and the risk of accidental vascular penetration with standardized injection is less than 0.03%;
The dermal layer has double the vessels (25 capillaries/cm²). Puncturing a vessel during injection allows the filler to travel with the blood flow, increasing the swelling rate 24 hours post-procedure from 12% to 35%;
The subcutaneous fat layer has even denser vessels (40 capillaries/cm²). If injected too deep, hitting a facial artery branch, the filler might migrate to the side of the nose, requiring dissolver to “chase” it back.
For example, choosing the supraperiosteal layer for nasolabial folds keeps the filler in place on the bone surface. Injecting into the dermal layer risks being “carried away” by vessels, reducing the retention rate by another 5%-8%.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dynamic Areas
In “active areas” like the perioral and periorbital regions, the layer must follow the muscle movement. The orbicularis oris muscle contracts over 10,000 times daily. Injecting into the dermal layer allows the filler to be “pushed” by the muscle to the corner of the mouth, with a retention rate 17% lower than in the supraperiosteal layer after 12 months.
The orbicularis oculi muscle is thinner (skin 0.3-0.5 millimeters). Injecting into the supraperiosteal layer easily pushes against the muscle, causing nodules. It is better to inject into the deep dermis—where the filler is “sandwiched” by collagen fibers just above the muscle, with a displacement rate of only 8% after 6 months, 12% lower than the dermal layer.
Static Areas
Although the frontalis muscle moves 10,000 times daily, the supraperiosteal layer acts like a “hard board,” supporting the filler and preventing compression. Retention rate after 12 months can reach 80%, 5% higher than the subcutaneous layer.
The temple’s subcutaneous fat is 1.5 millimeters thick. Injecting into the subcutaneous fat layer avoids the superficial temporal artery. The filler “settles” in the fat, metabolizes slowly, with a retention rate of 78%, 3% higher than the dermal layer.
Injection Speed Controls Distribution
Studies tracking 200 cheek augmentation patients found that those with an injection speed of 0.3 mL/second had the filler “scattered” after 6 months, with only 60% effective volume remaining;
Those injecting at 0.1 mL/second had the filler “clump” more tightly, retaining 78% of the effective volume. A speed difference of 0.2 mL/second resulted in a nearly 20% difference in effect.
Injecting Too Fast Causes “Disintegration”
When the injection speed exceeds 0.3 mL/second, the filler “squirts out like toothpaste” and disperses wildly.
The gaps in the skin’s dermal layer are only 0.05-0.1 millimeters wide. Too much pressure pushes the material out of the gaps and outside the target area.
For example, fast injection in the cheeks causes the filler to “leak” from the highest point of the cheekbone to the lateral cheek, resulting in a 15% lower cheek fullness after 6 months compared to slow injection.
High-speed injection generates “shear force,” tearing surrounding collagen fibers. The probability of facial swelling 24 hours post-procedure increases from 12% to 35%.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Slow Injection is More “Skin-Hugging”
Maintaining an injection speed of 0.1-0.2 mL/second allows the filler to “slide” into the target layer along the skin’s texture.
Studies show that slowly injected filler in the periorbital area has a displacement rate of only 8% after 12 months, much lower than the 25% rate from fast injection.
Slow injection also reduces compression on capillaries, lowering the probability of bruising from 20% to 5%, resulting in faster recovery.
Speed Must Be “Tailored to the Area”
Forehead skin is 1-2 millimeters thick. Slow injection (0.1 mL/second) allows the filler to “settle” into the deep layer, providing longer support;
Periorbital skin is thin, 0.3-0.5 millimeters. Injecting too fast can “puncture” the dermal layer. A medium speed of 0.15 mL/second is needed.
The nasolabial fold connects to the nasolabial sulcus, with muscle tension in the deep layer. The injection speed must be slower (0.1 mL/second) to prevent the filler from being “pulled away” by the muscle.
Don’t Inject Too Much in a Single Point
Studies tracking 100 cheek augmentation patients found that for those who injected over 0.3 mL in a single point, the filler “shrunk into a ball” after 6 months, with only 60% effective volume remaining;
Those who controlled the single point to 0.1-0.2 mL retained 85% of the volume, and the swelling time was reduced from 7 days to 3 days.
Compressing Vessels to the Point of “Suffocation”
The skin has 100-150 capillaries per square centimeter, responsible for delivering oxygen and nutrients to fibroblasts.
A single point exceeding 0.3 mL causes the filler to “stuff like a pillow,” compressing vessels and reducing blood supply by 40%.
For example, in cheek injections of over 0.3 mL per point, MMPs activity is 25% higher than with normal dosage, accelerating metabolism by 1 month, and the effect disappears faster.
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Different Areas Have Different “Filling Capacities”
Periorbital skin is as thin as 0.3-0.5 millimeters of paper. A single point of 0.1 mL is the limit—any more will “push” the skin, causing a bulge like “eye bags from a change in tear trough definition,” with a displacement rate as high as 25% after 6 months.
Forehead tissue is thick, 1-2 millimeters, accommodating 0.2-0.25 mL. The filler “settles” into the deep layer without feeling compressed, with a retention rate of 80%, 15% higher than the periorbital area.
The cheek is in the middle. 0.1-0.2 mL is just right, supporting the nasolabial fold without squeezing vessels.
Adjusting Dosage by Area Makes it “Durable”
For example, 0.05 mL in the periorbital area is more stable than 0.1 mL—while it may look less voluminous, it slowly integrates with collagen, with 70% of the effect remaining after 12 months;
In the forehead, 0.2 mL provides enough support for forehead lines without making the skin feel “tight,” resulting in a more natural touch.